Published in
American Society of Hematology, Blood, 23(131), p. 2541-2551
DOI: 10.1182/blood-2017-11-814608
Links
Tools
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Journal article published in 2018 by
Geffen Kleinstern 
,
Nicola J. Camp,
Lynn R. Goldin,
Celine M. Vachon,
Claire M. Vajdic,
Silvia de Sanjose,
J. Brice Weinberg,
Yolanda Benavente,
Delphine Casabonne,
Mark Liebow,
Alexandra Nieters,
Henrik Hjalgrim,
Mads Melbye,
Bengt Glimelius,
Hans-Olov Adami
and other authors.
,
Nicola J. Camp,
Lynn R. Goldin,
Celine M. Vachon,
Claire M. Vajdic,
Silvia de Sanjose,
J. Brice Weinberg,
Yolanda Benavente,
Delphine Casabonne,
Mark Liebow,
Alexandra Nieters,
Henrik Hjalgrim,
Mads Melbye,
Bengt Glimelius,
Hans-Olov Adami
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points PRS, based on the known CLL loci, predicts CLL risk with high discrimination. This PRS predicts risk of monoclonal B-cell lymphocytosis, a precursor to CLL and a condition that has clinical impact beyond risk for CLL.